A STEROID injection only relieves back pain for a maximum of three months, warns new research.

Back pain: Steroid injection ‘will only relieve agony for maximum of three months’

Sufferers of chronic lower back pain are often given an epidural injection if simple painkillers, stretching exercises or good posture fail.

Pain in the lower back is particularly common but generally goes away naturally.

But for reasons doctors do not know it can become chronic even if a cause was found such as a worn facet joint or disc with the pain continuing after the original problem has settled down.The long acting steroids reduces inflammation.

Following a randomised trial, French researchers found having a single intradiscal glucocorticoid injection reduced low back pain associated with active discopathy within a month.

Low back pain clearly has numerous causes, and many of these causes have a favourable natural history

Clinical Associate Professor Dr David Kennedy of Stanford University

But the effect decreased over time and by a year the pain had return to the same intensity as before the steroid jab.

Chronic lower back pain is a major cause of disability and those with the most severe form – known as Modic type 1 – are difficult to treat.

Active discopathy is associated with a specific phenotype of chronic low back pain with local inflammation playing a role in active discopathy-associated symptoms.

So reducing inflammation through steroid injections is thought to help.

Researchers at University Hospitals Paris conducted a prospective, parallel-group, double-blind, randomised, controlled study of 135 patients with chronic low back pain with active discopathy at three care centres in France.

They either had a single injection during discography or discography alone.

The patients rated the severity of their pain 48 hours before and at one, three, six and 12 months.

Patients who received a single intradiscal glucocorticoid injection reported positive effects on pain at one month compared with the control group.

Yet the effect decreased over time with no differences in low back pain intensity between groups at 12 months.

Professors Francois Rannou and Serge Poiraudeau said: “The increase in pain starting at three months could be related to a rebound effect of glucocorticoids.

“Furthermore, our population had a severe condition, with a low employment rate, symptoms of depression and anxiety, fear-avoidance beliefs, and inappropriate coping strategies, which could have altered the treatment effect.

“This effect decreased over time, with no differences in lower back pain intensity between groups at 12 months.

“The efficacy of a single glucocorticoid intradiscal injection as a possible treatment for chronic lower back pain associated with active discopathy is questionable, given the lack of long-term benefit.”

Commenting on the findings Clinical Associate Professor Dr David Kennedy of Stanford University said: “Low back pain clearly has numerous causes, and many of these causes have a favourable natural history.

“Thus, most patients with acute or subacute pain improve over time, regardless of therapy.

“Unfortunately, some patients progress to chronic low back pain, a leading cause of disability worldwide according to the World Health Organisation.

“Although some causes of low back pain may not have a favourable natural history, secondary factors are associated with chronic pain regardless of spinal pathology.

“The challenge of treating chronic low back pain is reflected in recent American College of Physicians guidelines that found that most noninvasive treatment options have little or no effect.

“How should clinicians apply the results of this study?

“In patients with an acute pain episode that coincides with Modic 1 changes on magnetic resonance imaging, glucocorticoid intradiscal injection may be an option for short-term pain relief.

“However, in patients with chronic pain, glucocorticoid injection clearly is not effective over the long term.

“The question then arises about the utility of using an invasive treatment for short term relief in the setting of an acute condition with a favourable natural history or for an acute flare of a chronic condition.”

He said more research was needed to answer this question.

The study was published in the journal Annals of Internal Medicine.

Posted on; Express.co.uk>>

Subscribe To Our Weekly NewsLetterAnd Get The Most Interesting News In Your Inbox Every SUNDAY!

Check Also

Dieneke had been diagnosed with the blood cancer myeloma in 2007 and had undergone three rounds of chemotherapy as well as four stem cell transplants

Curry spice helped a dying woman beat cancer

After five years of living with cancer and the ravages of side-effects from repeated unsuccessful treatment, Dieneke Ferguson thought she was finally losing the battle.

Leave a Reply

Your email address will not be published. Required fields are marked *